Kazia Therapeutics Limited ("Kazia" or the "Company")  today announced new data from two presentations at the 2025 San Antonio Breast Cancer Symposium (SABCS) providing compelling mechanistic and ...
When cells can’t destroy damaged proteins, a hidden backup system led by NRF1 steps in to prevent toxic buildup.
Everyone talks about turmeric and salmon when discussing anti-inflammation. You've heard it all before. Maybe you're tired of ...
CorriXR Therapeutics announced new peer-reviewed findings showing that its CRISPR-based gene-editing approach can resensitize squamous cell lung carcinoma (LUSC) tumors to standard chemotherapy, ...
This review synthesizes preclinical evidence showing that cinnamon-derived compounds can modulate inflammation, oxidative ...
EPFL scientists have identified a molecular pathway that protects cells from lipid oxidation and ferroptosis, a regulated ...
Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which healthy lung tissue is gradually replaced by scar tissue.
Pelareorep combined with standard chemotherapy achieved a 33% objective response rate in KRAS-mutant MSS mCRC, surpassing ...
Anthocyanin-rich purple foods contain plant pigments that influence antioxidant and inflammatory pathways and are linked in ...
Panelists discuss how faricimab’s dual VEGF-A and Ang-2 inhibition may offer vascular stability advantages over ...